STELLAR-001: A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Condition: Breast Cancer, Colorectal Cancer, Prostate Cancer, Renal Cancer, Urothelial Cancer
